Case File
efta-02034098DOJ Data Set 10OtherEFTA02034098
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-02034098
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
N.
N
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
1PMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
(W)
(F)
NN.
EFTA_R1_00545663
EFTA02034098
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Monday, January 24, 2011 1:38 PM
To: Barrett, Paul S
Subject: Re: HI
no to amr yes to digital fund send a chart on the turkey lire
On Mon, Jan 24, 2011 at 7:35 PM, Barrett, Paul S
Hi Jeffrey
A couple of things:
wrote:
1.
AMR Convert back down to 113.00. We have SIMM. I think we should buy another SIMM.
2.
We are launching a Digital Growth Fund — I think you should sign a NDA and see which names the
fund has committed to.
3.
We are going to offer separately managed accounts focusing on a) Internet Mobility b) Converts.
These will be daily liquidity with a 35bp management fee and 15% performance fee. Let me know if this is
of interest.
4. The Turkish Lira is down 11% since November. There was some technical selling by local banks
which we think is overdone. I think we should buy a 6 month 1.5250 TRY call for 6 months and finance it
with a 3 month 1.5600 TRY put with a 1.7000 Knock-In. This will pay us a small net credit.
Let me know
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
EFTA_R1_00545664
EFTA02034099
JPMorgan Private Bank
40W 57th Street, 33rd Floor, New York, NY 10019
(W)
(F)
This email is confidential and subject to important disclaimers and conditions including on offers
for the purchase or sale of securities, accuracy and completeness of information, viruses,
confidentiality, legal privilege, and legal entity disclaimers, available at
http://wwwjnmorzan.corn/pagcs/disclosurestemail.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00545665
EFTA02034100
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]URL
http://wwwjnmorzan.corn/pagcs/disclosurestemailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.